selective allosteric inhibitors of ROR-gamma-t (Merck)

N/A

Report date: 2025/01/26 15:37:12
NME

Base Information

Drug Nameselective allosteric inhibitors of ROR-gamma-t (Merck)
Drug Alias NameMRL-248
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis regulator Bcl-X degradersNuclear receptor ROR-gamma antagonists
TargetsApoptosis regulator Bcl-XNuclear receptor ROR-gamma
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesMerck & Co Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A